8:15 am Registration & Welcome Coffee

8:50 am Chair’s Opening Remarks

  • Jeremiah Genest Head of Quality Management Systems, Amylyx Pharmaceuticals Corp.

Protecting Data in the Cloud to Meet Regulatory Requirements

9:00 am Data Strategy & Governance – Moving Beyond Data Integrity in Life Sciences

  • Harry Wolfgang Leader, Technology Regulatory Compliance, Johnson & Johnson Services, Inc

Synopsis

  • Understanding the PIC/S guidance on data governance
  • Realizing the importance of a “data culture”
  • Maintaining compliance from a data perspective

9:30 am Unpacking The Impact of Regulatory Guidance on Cloud Computing

Synopsis

  • Exploring how regulatory guidance will impact GxP industry compliance with Cloud service providers (XaaS)
  • Ensuring accountability for compliance from sponsors and operating companies that are now required to meet specific expectations when using these services
  • Enhancing visibility into IaaS/PaaS/SaaS supplier actions and activities, aligning through risk-based assessments, and defining the intended use are necessary to maintain compliant infrastructure, platforms, and software

 

10:00 am Continuous Data Privacy and Compliance in Healthcare

  • Murali Mani Former Chief Compliance and Privacy Officer, GeneDx Inc

Synopsis

  • Accelerating compliance through tools and controls inheritance
  • The promise and challenges of Generative AI solutions
  • Continuous compliance and Audit readiness
  • Building trust and transparency with patients and data subjects

10:30 am Morning Break & Networking

11:00 am Panel Discussion: Harnessing Strategies to Maintain Data Integrity & Security in a Life Sciences Cloud Environment

Synopsis

  • Approaches to ensure data integrity, security and audit trail to meet regulatory requirements
  • Working with cloud providers to apply data integrity requirements necessary for the life sciences industry
  • Driving data integrity standards and overcoming the regulatory and business consequences of not protecting patient data

11:45 am Roundtable Discussions

  • Chris Clayton Director of Information Technology, INCOG BioPharma Services
  • Harry Wolfgang Leader, Technology Regulatory Compliance, Johnson & Johnson Services, Inc

Synopsis

  • This interactive session gives you the opportunity to be part of the discussion – to share ideas and learn from your peers. Choose the table most relevant to you and discuss how you are going to prepare for the future of:

agenda.PNG

12:30 pm Lunch Break & Networking

Implementing Risk Management Approaches for Cloud Compliance

1:30 pm Risk Management Based on Q9 R1 & Beyond

  • Yves Samson Member, ECA Data Integrity & IT Compliance Group

Synopsis

  • Regulation objectives and reasons for the revision
  • Changes and enhanced expectations
  • Beyond Q9 R1, an effective holistic approach

2:00 pm Implementing a Lifecycle of Risk Management Approach to the Cloud

  • Jeremiah Genest Head of Quality Management Systems, Amylyx Pharmaceuticals Corp.

Synopsis

  • Best practises to harness a life cycle risk management approach to protect product quality and patient data
  • What does a living risk assessment look like when key parts of your IT infrastructure are maintained by cloud service providers
  • How does Q9 R1 impact functional and usage assessments around cloud applications

Optimizing Security Strategies to Manage Cyber Threats

2:30 pm Panel Discussion: Leveraging Cybersecurity Tools When Moving to the Cloud in the Life Sciences Industry

  • Rob Morse Director of Information Technology, Accent Therapeutics
  • Chris Clayton Director of Information Technology, INCOG BioPharma Services

Synopsis

  • Security issues in the cloud, preventing manipulation, adhering to regulations
  • Implications to patient safety
  • Addressing cyber security risks, maintaining compliance from a security perspective 

3:15 pm Chair’s Closing Remarks

  • Jeremiah Genest Head of Quality Management Systems, Amylyx Pharmaceuticals Corp.

3:30 pm End of Conference